Analyst Recommendations

Jefferies analyst issues BUY recommendation for WB on November 19, 2024 05:27PM ET. The previous analyst recommendation was Buy.WB was trading at $8.9279 at issue of the analyst...

November 19, 2024   WB 0.93%

Goldman Sachs analyst issues BUY recommendation for AUTL on November 18, 2024 11:08AM ET. AUTL was trading at $3.08 at issue of the analyst recommendation.The overall analyst consensus...

November 18, 2024   AUTL 5.93%

Morgan Stanley analyst issues OVERWEIGHT recommendation for FUTU on November 18, 2024 04:38AM ET. The previous analyst recommendation was Equal-Weight.FUTU was trading at $89.08 at issue of the...

November 18, 2024   FUTU -1.06%

Deutsche Bank analyst issues HOLD recommendation for GSK on November 15, 2024 09:57AM ET. GSK was trading at $34.39 at issue of the analyst recommendation.The overall analyst consensus...

November 15, 2024   GSK 1.58%

Leerink Partners analyst issues OUTPERFORM recommendation for BNTX on November 13, 2024 12:26PM ET. The previous analyst recommendation was Outperform.BNTX was trading at $80.8 at issue of the...

November 13, 2024   BNTX 0.52%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for LEGN on November 13, 2024 12:21PM ET. The previous analyst recommendation was Overweight.LEGN was trading at $55.9 at issue of the...

November 13, 2024   LEGN -1.97%

Bank of America Securities analyst issues NEUTRAL recommendation for CEPU on November 11, 2024 12:09PM ET. The previous analyst recommendation was Neutral.CEPU was trading at $11.57 at issue...

November 11, 2024   CEPU 1.07%

Canaccord Genuity analyst issues BUY recommendation for CMPS on November 11, 2024 12:11PM ET. The previous analyst recommendation was Buy.CMPS was trading at $5.45 at issue of the...

November 11, 2024   CMPS 4.68%

Goldman Sachs analyst issues BUY recommendation for BNTX on November 8, 2024 09:06AM ET. The previous analyst recommendation was Buy.BNTX was trading at $107.88 at issue of the...

November 8, 2024   BNTX 0.52%

CLSA analyst issues OUTPERFORM recommendation for BIDU on November 8, 2024 05:43AM ET. The previous analyst recommendation was Outperform.BIDU was trading at $93.525 at issue of the analyst...

November 8, 2024   BIDU 0.11%